Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James A Bonner, MD
University of Alabama at Birmingham, Birmingham, AB, US
Principal Investigator - Jan Vermorken, MD, PhD
University Hospital, Antwerp, Belgium
Principal Investigator - Kevin Harrington, MBBS MRCP FRCR
The Royal Marsden Hospital, London, UK
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
77 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Zna Middelheim
Antwerp, Belgium
- University Hospital Antwerp
Edegem, Belgium
- Universitair Ziekenhuis Brussel
Jette, Belgium
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Juravinski Cancer Center
Hamilton, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Hopital Notre-Dame
Montreal, Quebec, Canada
- Hopital Saint-André / Service D'Oncologie-Radiothérapie
Bordeaux, France
- Centre Antoine Lacassagne / Oncologie Médicale
Nice, France
- Institut Curie / Département D'Oncologie Médicale
Paris, France
- Uke Hamburg
Hamburg, Germany
- Attikon University Hospital
Athens, Greece
- Fovarosi Onkormanyzat Uzsoki Utcai Kórház
Budapest, Hungary
- Orszagos Onkologiai Intezet
Budapest, Hungary
- Pecsi Tudomanyegyetem
Pécs, Hungary
- Szegedi Tudományegyetem
Szegedi, Hungary
- Markusovszky Korhaz
Szombathely, Hungary
- Ufficio Sperimentazioni Cliniche C/o S.C. Oncologia Medica
Cuneo, Italy
- Fondazione Irccs Istituto Nazionale del Tumori
Milan, Italy
- Ospedale San Paolo - Oncologia Medica
Milan, Italy
- University Hospital in Modena
Modena, Italy
- Centrum Onkologii - Instytyt Im.M.Skłodowskiej-Curie
Krakow, Poland
- Wojewódzki Szpital Specjalistyczny Im. M.Kopernika
Lodz, Poland
- Szpital Mswia - Centrum Onkologi
Olsztyn, Poland
- Wielkopolskie Centrum Onkologii
Poznan, Poland
- State Health Care Institution "arkhangelsk Regional Clinical Oncology Dispensary"
Arkhangelsk, Russia
- Regional State Health Care Institution "belgorod Oncology Dispensary"
Belgorod, Russia
- State Health Care Institution "chelyabinsk Regional Oncology Dispensary"
Chelyabinsk, Russia
- State Health Care Institution "republican Clinical Oncology Dispensary of Ministry of Health of the Republic of Tatarstan"
Kazan', Russia
- State Budgetary Health Care Institution "clinical Oncology Dispensary #1" of Krasnodar Region Health Care Department
Krasnodar, Russia
- Regional Budgetary Health Care Institution "kursk Regional Oncology Dispensary" of Health Care Committee of Kursk Region
Kursk, Russia
- Federal State Budgetary Institution "medical Research Radiology Center" of Ministry of Public Health and Social Development of Russian Federation, Obninsk
Obninsk, Russia
- Federal State Budgetary Institution "n. N. Petrov Oncology Research Institute" of Ministry of Public Health and Social Development of the Russian Federation
Saint Petersburg, Russia
- Federal State Budgetary Institution "russian Research Centre of Radiology and Surgery Technologies" of Ministry of Public Health and Social Development of the Russian Federation
Saint Petersburg, Russia
- St.Petersburg State Health Care Institution City Clinical Oncology Dispensary"
Saint Petersburg, Russia
- State Health Care Institution "oncology Dispensary №2" of Krasnodar Region Health Care Department
Sochi, Russia
- State Health Care Institution "tula Regional Oncology Dispensary"
Tula, Russia
- State Budgetary Healthcare Institution "republic Clinical Oncology Dispensary Ministry of Health of Bashkortostan"
Ufa, Russia
- State Budgetary Health Care Institution of the Yaroslavl Region "regional Clinical Oncological Hospital"
Yaroslavl, Russia
- Institute of Oncology Ljubljana
Ljubljana, Slovenia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 30 Apr 2012
- Completion
- 31 May 2014
- Last update posted
- 5 Nov 2014
- Registered enrollment
- 167
- Registry id
- NCT01166542
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.